Literature DB >> 8864127

Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.

J A Johnston1, C M Bacon, M C Riedy, J J O'Shea.   

Abstract

Cytokines that bind to the interleukin-2 (IL-2) receptor common gamma chain (gamma c), including IL-2, IL-4, IL-7, IL-9, and IL-15, are important for the growth and differentiation of T and B lymphocytes, natural killer cells, macrophages, and monocytes. These cytokines have overlapping biological effects that in part result from the use of the shared receptor subunit gamma c. Recently it has become clear that these cytokines activate a number of important intracellular signaling molecules, including the Janus kinases JAK1 and JAK3 and members of the transcription factor family of signal transducers and activators of transcription (STATs). The discovery of these signaling pathways has led to important new insights into their role in lymphocyte maturation, as it has emerged that mutations in the genes encoding both gamma c and JAK3 result in similar forms of severe combined immunodeficiency (SCID). In this review we examine the structure and function of cytokine receptors and the signaling pathways involved in their regulation of gene expression. Furthermore, we discuss recent advances that have led to a better understanding of how cytokines elicit intracellular responses, as well as their role in normal lymphoid development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864127     DOI: 10.1002/jlb.60.4.441

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  32 in total

1.  Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cell-free system.

Authors:  M L Vignais; M Gilman
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 2.  Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disorders.

Authors:  Spencer Ng; Jacques Galipeau
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 3.  Gene therapy of X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

4.  Changes in cytokine levels during reactivation of Toxoplasma gondii infection in lungs.

Authors:  G A Filice; C R Clabots; P E Riciputi; O Goñi-Laguardia; C Pomeroy
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  CD25+CD4+ T cells contribute to the control of memory CD8+ T cells.

Authors:  Masaaki Murakami; Akemi Sakamoto; Jeremy Bender; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

6.  Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.

Authors:  Sujatha Muralidharan; Patrick J Hanley; Enli Liu; Rikhia Chakraborty; Catherine Bollard; Elizabeth Shpall; Cliona Rooney; Barbara Savoldo; John Rodgers; Gianpietro Dotti
Journal:  J Immunol       Date:  2011-10-19       Impact factor: 5.422

Review 7.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

Review 8.  Roles of TRAF3 in T cells: many surprises.

Authors:  Zuoan Yi; Alicia M Wallis; Gail A Bishop
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling.

Authors:  Ashley Mentlik James; Hsiang-Ting Hsu; Prachi Dongre; Gulbu Uzel; Emily M Mace; Pinaki P Banerjee; Jordan S Orange
Journal:  Blood       Date:  2013-02-04       Impact factor: 22.113

10.  Development of Selective Covalent Janus Kinase 3 Inhibitors.

Authors:  Li Tan; Koshi Akahane; Randall McNally; Kathleen M S E Reyskens; Scott B Ficarro; Suhu Liu; Grit S Herter-Sprie; Shohei Koyama; Michael J Pattison; Katherine Labella; Liv Johannessen; Esra A Akbay; Kwok-Kin Wong; David A Frank; Jarrod A Marto; Thomas A Look; J Simon C Arthur; Michael J Eck; Nathanael S Gray
Journal:  J Med Chem       Date:  2015-08-18       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.